Hoffman-La Roche ordered to pay a total of $18 million in damages
On June 29, 2012, Hoffman-La Roche was ordered to pay a total of $18 million in damages to two former users of its acne drug Accutane. Jurors in a New Jersey state court found that Roche failed to properly warn the plaintiffs Kathleen Rossitto and Riley Wilkinson that Accutane could cause inflammatory bowel disease. Rossitto and Wilkinson were each awarded $9 million in compensatory damages. At the same time, the panel rejected claims by two other former users of the drug.
About 16 million people have taken Accutane, once Roche’s second-biggest selling drug, since it went on the market in 1982, according to plaintiffs’ lawyers. Roche, pulled its brand-name version of Accutane off the market in 2009 after juries awarded millions of dollars in damages over bowel-disease claims.
The verdicts come about a week after European regulators said Roche systematically failed to evaluate reports of safety issues involving its products to determine whether they should be passed on to health authorities.
The European Medicines Agency said June 21 that it found no evidence patients were harmed by the deficiencies in Roche’s drug-safety reporting. Still, regulators found about 80,000 reports involving medicines marketed in the U.S. that hadn’t been evaluated to determine whether they should be given to the EU as suspected adverse reactions.
To read the full article please click the below link.http://www.bloomberg.com/news/2012-06-29/roche-ordered-to-pay-18-million-to-former-accutane-users.html
Free Case Evaluation
Thank You! Thank you for your recent inquiry. I, or a member of my
staff will contact you by e-mail or telephone to obtain further details.
Send Email Instead Sorry, There was a problem sending your request. Click the button above to send me an email at email@example.com. I, or a member of my staff will contact you by e-mail or telephone to obtain further details of your Accutane ingestion.